M. Asadakubota et al., THE TARGET-CELLS OF INJECTED TYPE-I INTERFERONS IN MOUSE-LIVER, Journal of interferon & cytokine research, 18(2), 1998, pp. 71-74
Type I interferons (IFNs) have been used for the treatment of viral he
patitis, but it is unclear which cells in the liver are affected by in
jected IFN, The effects of IFN have been studied by the production of
2',5'-oligoadenylate synthetase (2'5'OAS), an IFN-inducible enzyme, He
re, we studied the distribution of 2'5'OAS in mouse liver after inject
ion of natural mouse IFN-alpha/beta by Western blotting and immunohist
ochemistry using a monoclonal antibody specific to mouse 42-kDa 2'5'OA
S, Injection of IFN-alpha/beta increased the levels of liver 2'5'OAS a
nd enhanced the intensities of immunohistochemical staining for this e
nzyme in both hepatocytes and Kupffer cells, In IFN-untreated normal m
ice, hepatocytes were lightly stained, but some of the Kupffer cells s
howed rather strong staining, The 2'5'OAS-positive Kupffer cells compr
ised similar to 60% of those in normal liver, whereas this increased t
o similar to 90% following IFN-alpha/beta injection, Thus, hepatocytes
and Kupffer cells were the targets of injected IFN.